Evaluation of bone mineral density of the peripheral skeleton in pre- and postmenopausal women with newly diagnosed endogenous Cushing's syndrome
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Cushing's syndrome (CS) is a well recognized cause of bone loss. Although many previous studies have shown decreased bone mineral density (BMD) in the lumbar spina and proximal femur of patients with endogenous CS, so far, the data estimating BMD in their peripheral skeleton are sparse. The aim of the present study was to evaluate BMD in the forearm and heel of women with newly diagnosed CS and to investigate its possible correlation with serum osteocalcin (BGP) and 24-hour urinary free cortisol levels (UFC). PATIENTS AND METHODS: BMD in the forearm (distal and ultradistal area) of 29 (13 premenopausal and 16 postmenopausal) women with newly diagnosed CS (18 with pituitary adenoma, 10 with adrenal tumor and 1 with ectopic) was measured by dual x-ray absorptiometry (DEXA) and was compared with BMD of 29 age, body mass index (BMI)- and oestrogen status matched healthy controls. Furthermore, in 18 (9 premenopausal and 9 postmenopausal) of the above patients (14 with pituitary adenoma, 5 with adrenal tumor and 1 with ectopic) broadband ultrasound attenuation (BUA) by quantitative ultrasound (QUS) of the heel was estimated and 18 age-, BMI- and oestrogen status matched healthy women served as controls. In all the patients serum BGP and UFC were measured at the time of diagnosis of CS. RESULTS: Compared to their matched controls, BMD in the forearm and BUA values in the heel did not differ in the premenopausal women with CS, while in the postmenopausal group BMD in the forearm was decreased (P < 0.05) but not BUA. Apart from a weak negative correlation between serum BGP and BMD in the ultradistal site of the forearm in premenopausal women (P = 0.05), serum BGP and UFC did not show significant correlation with BMD or BUA. CONCLUSIONS: BMD in the forearm is reduced only in postmenopausal women with newly diagnosed endogenous CS, while BUA in the heel is unaffected in both pre- and postmenopausal patients. Moreover, serum BGP and UFC do not seem to be relevant markers for assessing bone loss in the peripheral skeleton at the time of diagnosis of hypercortisolemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis
Staa, T. P. V., Staa, T. P. V., Staa, T. P. V., Leufkens, H. G. M., & Cooper, C. (2002) · Osteoporosis International · doi:10.1007/s001980200108 · Cited by 1,294 · cited 2×
“…premenopausal ones (4·21 ± 2·85 vs. 2·26 ± 1·34 years), it is of note that during glucocorticoid treatment bone loss seems to occur predominantly within the first 6–12 months, followed by a much lower annual reduction rate (LoCascio et al., 1990; Manolagas & Weinstein, 1999; Van Staa et al., 2002).”
BackgroundUse of oral corticosteroids and risk of fractures
Van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.993 · Cited by 1,263 · cited 5×
“Although it could be argued that the estimated duration of symptomatic glucocorticoid excess was longer in postmenopausal women compared to premenopausal ones (4·21 ± 2·85 vs. 2·26 ± 1·34 years), it is of note that during glucocorticoid treatment bone loss seems to occur predominantly within the first 6–12 months, fol…”
BackgroundInfluentialAlendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258 · cited 2×
“…the issue of the protective effects of endogenous steroids is also raised in randomized placebo-controlled trials of biphosphonates, in which the placebo arms of glucocorticoid-treated premenopausal women showed very low vertebral fracture rates (Saag et al., 1998; Wallach et al., 2000).”
BackgroundCarbonare, L. D., Arlot, M. E., Chavassieux, P. M., Roux, J. P., Portero, N. R., & Meunier, P. J. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.1.97 · Cited by 309
Sartorio, A., Conti, A., Ferrero, S., Giambona, S., Re, T., Passini, E., & Ambrosi, B. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380146 · Cited by 84
Bone metabolism and mass in women with Cushing’s syndrome and adrenal incidentaloma
Francucci, C. M., Pantanetti, P., Garrapa, G. G., Massi, F., Arnaldi, G., & Mantero, F. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01602.x · Cited by 65 · cited 1×
“Similarly, in patients with CS, no correlation has been found between BGP and BMD in the lumbar spine and proximal femour (Pantanetti et al., 2002).”
Background
Cited by
Mancini, T., Doga, M., Mazziotti, G., & Giustina, A. (2004) · Pituitary · doi:10.1007/s11102-005-1051-2 · Cited by 144
Glucocorticoid‐induced osteoporosis: lessons from Cushing's syndrome
Tóth, M., & Grossman, A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12189 · Cited by 81
Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism
Tauchmanovà, L., Pivonello, R., De Martino, M. C., Rusciano, A., De Leo, M., Ruosi, C., Mainolfi, C., Lombardi, G., Salvatore, M., & Colao, A. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0137 · Cited by 80
“Considering the effects of estrogens, both exogenous and endogenous cortisol excess have been shown to cause more severe bone damage in postmenopausal than reproductive-aged women (22, 23 ).”
Skeletal involvement in adult patients with endogenous hypercortisolism
Chiodini, I., Torlontano, M., Carnevale, V., Trischitta, V., & Scillitani, A. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345601 · Cited by 78
Skeletal Diseases in Cushing’s Syndrome: Osteoporosis versus Arthropathy
Kaltsas, G., & Makras, P. (2010) · Neuroendocrinology · doi:10.1159/000314298 · Cited by 71
“In patients with CS, a significant reduction of lumbar spine bone density develops before involvement of the peripheral skeleton [”
Background
Metadata
- Authors
- Karavitaki, N., Ioannidis, G., Giannakopoulos, F., Mavrokefalos, P., & Thalassinos, N.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2004-02
- Volume
- 60
- Issue
- 2
- Pages
- 264-270
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2107769690
- Cited by
- 28
- References
- 7
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of bone mineral density of the peripheral skeleton in pre- and postmenopausal women with newly diagnosed endogenous Cushing's syndrome. https://app.cochat.ai/papers/10.1111/j.1365-2265.2004.01968.x
- The paper
- Karavitaki, N., Ioannidis, G., Giannakopoulos, F., Mavrokefalos, P., & Thalassinos, N. (2004). Evaluation of bone mineral density of the peripheral skeleton in pre- and postmenopausal women with newly diagnosed endogenous Cushing's syndrome. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2004.01968.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.